---
document_datetime: 2023-09-21 18:17:47
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/qutenza-epar-all-authorised-presentations_en.pdf
document_name: qutenza-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1571602
conversion_datetime: 2025-12-26 13:38:07.47849
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented   | Strength   | Pharmaceutical   | Route of       | Packaging   | Package size                |
|-----------------|------------|------------|------------------|----------------|-------------|-----------------------------|
|                 | name       |            | Form             | Administration |             |                             |
| EU/1/09/524/001 | Qutenza    | 179 mg     | Cutaneous patch  | Cutaneous use  | sachet      | 1 patch + 1 cleansing gel   |
| EU/1/09/524/002 | Qutenza    | 179 mg     | Cutaneous patch  | Cutaneous use  | sachet      | 2 patches + 1 cleansing gel |